129 related articles for article (PubMed ID: 38616361)
41. Management of extramedullary leukemia as a presentation of acute myeloid leukemia.
Slomowitz SJ; Shami PJ
J Natl Compr Canc Netw; 2012 Sep; 10(9):1165-9. PubMed ID: 22956813
[TBL] [Abstract][Full Text] [Related]
42. Treatment of Childhood Acute Myeloid Leukemia in Bulgaria.
Burnusuzov HA; Yordanova MN; Avramova BE; Yurukova NN; Bachvarov KN; Muchinova AB; Vlahova IH; Stoyanova AA; Mumdzhiev IN; Ivanova LR; Spasov NY; Peteva ET; Belcheva MI; Hristozova H; Spasova MI; Kaleva VI; Bobev D; Konstantinov DN
Folia Med (Plovdiv); 2018 Jun; 60(2):234-240. PubMed ID: 30355812
[TBL] [Abstract][Full Text] [Related]
43. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group.
Kawasaki H; Isoyama K; Eguchi M; Hibi S; Kinukawa N; Kosaka Y; Oda T; Oda M; Nishimura S; Imaizumi M; Okamura T; Hongo T; Okawa H; Mizutani S; Hayashi Y; Tsukimoto I; Kamada N; Ishii E
Blood; 2001 Dec; 98(13):3589-94. PubMed ID: 11739161
[TBL] [Abstract][Full Text] [Related]
44. Extramedullary Infiltration in Pediatric Acute Myeloid Leukemia on Surveillance Magnetic Resonance Imaging and its Relationship With Established Risk Factors.
Kim EH; Im SA; Lee JW; Kim S; Cho B
J Pediatr Hematol Oncol; 2022 Apr; 44(3):e713-e718. PubMed ID: 35319510
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center.
Jaime-Pérez JC; Padilla-Medina JR; Fernández LT; Herrera-Garza JL; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Gómez-Almaguer D
Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):286-292. PubMed ID: 29478946
[TBL] [Abstract][Full Text] [Related]
46. [Analysis of the characteristics of primary acute myeloid leukemia with 11q23/KMT2A rearrangements in ninety patients].
Li Y; Wang Y; Wang Z; Feng L; Gao L; Shi Y; Dang H; He Q; Qin Y; Jiang Q; Jiang H; Huang X; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Dec; 40(12):1472-1477. PubMed ID: 37994126
[TBL] [Abstract][Full Text] [Related]
47. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome.
Mason EF; Hasserjian RP; Aggarwal N; Seegmiller AC; Pozdnyakova O
Blood Adv; 2019 Nov; 3(21):3322-3332. PubMed ID: 31698462
[TBL] [Abstract][Full Text] [Related]
48. Aleukemia cutis: Clinicopathological and molecular investigation of two cases.
Azari-Yaam A; Safavi M; Ghanadan A
J Cutan Pathol; 2020 Aug; 47(8):747-754. PubMed ID: 32196719
[TBL] [Abstract][Full Text] [Related]
49. The role of matched sibling donor allogeneic stem cell transplantation in pediatric high-risk acute myeloid leukemia: results from the AML-BFM 98 study.
Klusmann JH; Reinhardt D; Zimmermann M; Kremens B; Vormoor J; Dworzak M; Creutzig U; Klingebiel T
Haematologica; 2012 Jan; 97(1):21-9. PubMed ID: 21933851
[TBL] [Abstract][Full Text] [Related]
50. Mutational landscape and clinical outcome of pediatric acute myeloid leukemia with 11q23/KMT2A rearrangements.
Yuen KY; Liu Y; Zhou YZ; Wang Y; Zhou DH; Fang JP; Xu LH
Cancer Med; 2023 Jan; 12(2):1418-1430. PubMed ID: 35833755
[TBL] [Abstract][Full Text] [Related]
51. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
Eckardt JN; Stölzel F; Kunadt D; Röllig C; Stasik S; Wagenführ L; Jöhrens K; Kuithan F; Krämer A; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Kroschinsky F; Berdel WE; Ehninger G; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Bornhäuser M; Thiede C; Middeke JM
J Hematol Oncol; 2022 May; 15(1):60. PubMed ID: 35562747
[TBL] [Abstract][Full Text] [Related]
52. Identification of A-kinase interacting protein 1 as a potential biomarker for risk and prognosis of acute myeloid leukemia.
Yan Y; Li X; Gao J
J Clin Lab Anal; 2020 May; 34(5):e23055. PubMed ID: 32356617
[TBL] [Abstract][Full Text] [Related]
53. Pediatric acute myeloid leukemia patients with
Yang W; Qin M; Jia C; Yang J; Chen W; Luo Y; Jing Y; Wang B
Hematology; 2022 Dec; 27(1):583-589. PubMed ID: 35617149
[TBL] [Abstract][Full Text] [Related]
54. The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
Pediatr Blood Cancer; 2010 Sep; 55(3):414-20. PubMed ID: 20658610
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
[TBL] [Abstract][Full Text] [Related]
56. [Prognostic value of early treatment response in children with acute myeloid leukemia].
Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
[TBL] [Abstract][Full Text] [Related]
57. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.
Goyal SD; Zhang MJ; Wang HL; Akpek G; Copelan EA; Freytes C; Gale RP; Hamadani M; Inamoto Y; Kamble RT; Lazarus HM; Marks DI; Nishihori T; Olsson RF; Reshef R; Ritchie DS; Saber W; Savani BN; Seber A; Shea TC; Tallman MS; Wirk B; Bunjes DW; Devine SM; de Lima M; Weisdorf DJ; Uy GL
Bone Marrow Transplant; 2015 Aug; 50(8):1057-62. PubMed ID: 25915806
[TBL] [Abstract][Full Text] [Related]
58. Umbilical cord blood transplantation can overcome the poor prognosis of KMT2A-MLLT3 acute myeloid leukemia and can lead to good GVHD-free/relapse-free survival.
Tong J; Zhang L; Liu H; Xu X; Zheng C; Yao W; Zhu X; Tang B; Wan X; Song K; Zhang X; Sun G; Sun Z
Ann Hematol; 2021 May; 100(5):1303-1309. PubMed ID: 33469688
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]